The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting...
The SIMD meeting will be held April 10-13 2022 at the Rosen Shingle Creek Resort in Orlando, Florida. Note: Safety protocols will be in effect, and attendees will be required to verify Covid-19 vaccination (see General Information). The meeting will feature sessions on: The Continuum of Hope: a session on n=1 treatments for inborn errors of metabolism...
Live and in person *NEW DATES*: APRIL 12-14, 2022 @ the Oakland Marriott City Center. After TWO years of digital meetings, we’re bringing synthetic biology’s leading community of innovators, investors, engineers,… Because Being in the Same Room is Better Than Being on the Same Zoom, and we really miss you!
The Fierce Promotional Review Committee Compliance and Best Practices Summit will allow cross-functional professionals involved in promotional review boards across large pharma and biotech organizations to learn how to collaborate more effectively and ensure quicker reviews of advertising materials, while staying compliant.
The Fierce Medical Affairs Strategic Summit is an educational community that provides a holistic view of medical affairs, allowing organizations to develop a unified scientific voice. Join us and interact with medical affairs colleagues as we tackle different stages of the product lifecycle, from evidence generation to Phase 4 studies, to ensure both internal and...
California Life Sciences invites you to join us and our Southern California members to connect over award-winning beer, appetizers and patio games at Ballast Point’s largest brewery and outdoor restaurant. Don’t miss the opportunity to connect with San Diego’s life science community. This event is closed to service provider companies that are not members of...
Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry is a dynamic in-person and online event for medicinal and biophysical chemists working in pharma, biotech, and academia. Nearly 800 attendees participated virtually this year, with 71% of delegates from pharma/biotech and 16% from academia. 60% of attendees were scientists/technologists and...
Over the years, we have witnessed unprecedented success, advancement, and investment in biotech R&D. As a result, R&D competition is as fierce as it has ever been. But many companies are only focused on their progress of assets and portfolios and that inward-facing diligence typically does not incorporate a rational, pragmatic, and unbiased view of...
The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 80+ dedicated...
Join Biocom California and the U.S. Commercial Service of the U.S. Department of Commerce for a live webinar about biotech expansion opportunities in Germany and the U.K. The panel will discuss how the CS can assist Bay Area biotechs with resources, USG assistance, and inroads to the German and U.K. markets. Featured speakers from Bay Area-based Gritstone Bio and Invitae will...
How does the current economic environment affect the biotech venture investor mindset and outlook? How should you position your company and cater your pitch for success? Join our expert panel for an informative and eye-opening webinar. Speakers: —Mike Powell, Executive Partner, Omega Funds —Shobha Parthasarathi, Vice President, Xontogeny —Kanad Das, Investment Director, Boehringer Ingelheim Venture...
Cell & Gene therapies are the latest revolution in medicine manufacturing. Unlike small molecules or traditional biotech products, these therapies introduce cells and genes into a patient to treat the underlying cause of a disease—they are living medicines! Whether you are producing biologic drug substance, conducting sterile fill-finish operations, or entering into cell and gene...
